Could a white blood cell booster help shrink breast tumors?
NCT ID NCT03571633
First seen Nov 20, 2025 · Last updated May 15, 2026 · Updated 20 times
Summary
This study looks at whether adding pegfilgrastim (a drug that increases white blood cells) to standard chemotherapy and trastuzumab can help eliminate more cancer cells before surgery in women with early-stage HER2-positive breast cancer. About 90 participants will receive either the standard treatment or the standard treatment plus pegfilgrastim. The main goal is to see if more tumors completely disappear with the added drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU Besançon
Besançon, 25000, France
-
Centre Hospitalier Annecy Genevois
Pringy, France
-
Centre Hospitalier Universitaire de Saint Etienne
Saint-Etienne, France
-
Centre Leon Berard
Lyon, France
-
Centre de Lutte contre le Cancer Jean Perrin
Clermont-Ferrand, 63000, France
-
Clinique Charcot
Sainte-Foy-lès-Lyon, France
-
Groupe Hospitalier Mutualiste de Grenoble
Grenoble, 38000, France
-
Hopital Prive Jean Mermoz
Lyon, France
-
Institut Sainte Catherine
Avignon, France
Conditions
Explore the condition pages connected to this study.